MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'fluoxetine'. Sat, 03 Sep 2011 02:21:45 +0100 http://www.medworm.com/index.php?rid=3271000&cid=t_142711_83_f&fid=34856&url=http%3A%2F%2Finsidesurgery.com%2F2010%2F02%2Fmajor-depression%2F Pathophysiology 1) depressed mood daily for a minimum of 14 days 2) not associated with general medical condition or bereavement Signs and Symptoms 1) diminished pleasure or interest in daily activities 2) sadness, thoughts of death, suicidal ideation 3) irritability 4) feelings of hopelessness or worthlessness 5) insomnia or hypersomnia 6) early morning awakening 7) fatigue weight loss or gain 9) decrease in concentration and/or ability to make decisions Characteristic Test Findings Laboratory – 1) decreased plasma tryptophan 2) increased plasma cortisol Radiology – 3) PET scan shows decreased glucose metabolism in caudate nucleus and frontal lobes Histology/Gross Pathology decreased noradrenergic neurons in locus ceruleus Associated Conditions 1) suicide (15%) 2) bipolar dis... Inside Surgery blogs http://www.medworm.com/rss/comments.php?id=3271000 Sun, 14 Feb 2010 00:04:26 +0100 3271000 http://www.medworm.com/index.php?rid=2309570&cid=t_142711_97_f&fid=35606&url=http%3A%2F%2Fwww.theangriestpharmacist.com%2F2009%2F04%2F05%2Fbilking-multiple-sclerosis-and-compromised-ethics%2F Update: Funny note before serious story — theangriestpharmacist.org is now mine. I have no idea why it affected me, but it did. After I hung up the phone, I was angrier than usual — pissed off even. It wasn’t a new thing, a patient knowing more than their pharmacist. Hell, that’s the norm, right? But, for whatever reason, this was different. This was personal. I got the script, put it in, and submitted it to the insurance. It rejected. Today is 4/4/09. It was filled on 3/25/09 for a 30-day supply. Insurance would pay for it on 4/20/09. The drug? Diazepam 10mg po BID #60. What happened to her OTHER FORTY tablets? So, I called her to let her know that I wasn’t going fill it. As a little back story, there is another pharmacist that had managed my store for 25-30 ... The Angriest Pharmacist blogs http://www.medworm.com/rss/comments.php?id=2309570 Sun, 05 Apr 2009 08:27:01 +0100 2309570 http://www.medworm.com/index.php?rid=2287312&cid=t_142711_111_f&fid=36048&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2FB8JEpCXn3AM%2F Two announcements, one today and one last week, tell us of new drug indication approvals for medications used to treat depression. Symbyax (olanzapine and fluoxetine HCl capsules) manufactured by Eli Lilly and Company was originally approved for treatment of bipolar depression. It’s now approved for acute treatment of treatment-resistant depression. This means if you’ve been treated with other medications for your depression without success, this medication may be tried and may work for you. It gives doctors another tool. The FDA has also approved a change in indication for Lexapro (escitalopram oxalate ) for the acute and maintenance treatment of Major Depressive Disorder (MDD) in adolescents, 12 - 17 years of age. Before the approval, there was only one medication approved f... A Hearty Life blogs http://www.medworm.com/rss/comments.php?id=2287312 Mon, 23 Mar 2009 13:40:19 +0100 2287312 http://www.medworm.com/index.php?rid=1358536&cid=t_142711_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2008%2F04%2F08%2Fprozac-kids-and-long-term-treatment%2F Is Prozac (fluoxetine) a good long-term treatment for children and teens grappling with depression to help prevent relapse? According to a study published in this month’s American Journal of Psychiatry, the answer appears to be, “Yes.” The researchers examined 168 children and adolescents ages 7 to 18. The study looked at whether or not a person relapsed, and how quickly, as the primary outcome measure. In the group of kids taking Prozac, 42% relapsed within 6 months after being stabilized on the medication (9 months after starting treatment). In the group of kids taking a placebo, 69% relapsed in the same time period. Prozac is called a selective serotonin reuptake inhibitor or SSRI, and is a popularly prescribed antidepressant medication for adults and children. Us... World of Psychology blogs http://www.medworm.com/rss/comments.php?id=1358536 Tue, 08 Apr 2008 20:33:27 +0100 1358536 http://www.medworm.com/index.php?rid=1284875&cid=t_142711_151_f&fid=35818&url=http%3A%2F%2Frecoveryissexy.com%2Fare-antidepressants-effective%2F   A recent analysis of studies of the effectiveness of Selective Serotonin Reuptake Inhibitor (SSRI’s) antidepressants found that only people with severe forms of depression show any benefit from the antidepressants studied. It also claimed that, in people with milder depression, the response to the antidepressants was no better than a placebo (i.e. a dummy pill). The drugs studied included Prozac (fluoxetine), Seroxat (marketed as Aropax or paroxetine in Australia), Effexor (venlafaxine) and Serzone (nefazodone, which is no longer prescribed in Australia). The results were published in the US journal Public Library of Science Medicine in an article titled Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data submitted to the Food and Drug Administration. The... Recovery Is Sexy.com blogs http://www.medworm.com/rss/comments.php?id=1284875 Fri, 07 Mar 2008 01:10:15 +0100 1284875 http://www.medworm.com/index.php?rid=1007607&cid=t_142711_109_f&fid=35671&url=http%3A%2F%2Fwww.anxietyinsights.info%2Fbehavior_therapy_plus_antidepressant_best_for_substance_abus.htm The antidepressant fluoxetine (Prozac®) combined with cognitive behavior therapy appears as effective for treating depression among teens who also have substance use disorders as among those without substance abuse problems, according to a report in the November issue of Archives of Pediatrics & Adolescent Medicine. "Adolescents with substance use disorders (SUDs) have higher rates of depression (15 percent to 24 percent) than adolescents in the general population," the authors write as background information in the article. "Comorbid [co-occuring] depression is also associated with more severe substance abuse, poorer drug treatment outcomes and higher relapse rates." Paula D. Riggs, M.D., and colleagues at the University of Colorado Denver conducted a randomized controlled trial o... Latest entries from www.anxietyinsights.info blogs http://www.medworm.com/rss/comments.php?id=1007607 Tue, 06 Nov 2007 07:46:00 +0100 1007607 http://www.medworm.com/index.php?rid=919064&cid=t_142711_109_f&fid=35671&url=http%3A%2F%2Fwww.anxietyinsights.info%2Fcombination_ofpsychotherapy_plus_prozacreg_best_for_depress.htm A combination of antidepressant drugs and cognitive behavior therapy is the most effective approach when treating teens suffering from major depressive disorder (MDD), according to a long-term study led by a Duke University Medical Center psychiatrist. The findings of the Treatment for Adolescents with Depression Study (TADS), published in the October issue of the Archives of General Psychiatry, indicate that combination therapy improved depressive symptoms and reduced the level of suicidal thinking and behavior in adolescents. "Depression among teenagers is a significant public health problem and there has been a tremendous need to identify treatments that work and are also safe," said John March, M.D., chief of child and adolescent psychiatry at Duke University and lead investigator on t... Latest entries from www.anxietyinsights.info blogs http://www.medworm.com/rss/comments.php?id=919064 Tue, 02 Oct 2007 08:29:00 +0100 919064 http://www.medworm.com/index.php?rid=822295&cid=t_142711_109_f&fid=34699&url=http%3A%2F%2Fscienceblogs.com%2Fcorpuscallosum%2Fimages%2Ffluoxetine%2520structure.JPG This controversy has been evolving for the past three years.  Perhaps at this point it is no longer newsworthy.  But often, after a topic fades from the radar of the MSM, there are new findings. The journal, Psychological Medicine, has published a study about the risk of suicidal thinking and behavior in persons treated with an antidepressant (fluoxetine) for conditions other than depression.   Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder SITRA TAUSCHER-WISNIEWSKI, DAMON DISCH, JOHN PLEWES, SUSAN BALL and CHARLES M. BEASLEY Jr doi:10.1017/S0033291707001146 Published online by Cambridge University Press 20 Jul 2007 Read the rest of this post... | Read the comme... The Corpus Callosum blogs http://www.medworm.com/rss/comments.php?id=822295 Sat, 25 Aug 2007 19:13:25 +0100 822295